Investor Alert: Pomerantz Law Firm Investigates ARS Pharmaceuticals for Potential Securities Fraud
Pomerantz LLP is investigating potential securities fraud or other unlawful business practices by ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) and its officers following a significant drop in the company's stock price after it announced that its product neffy® failed to secure commercial insurance coverage.
Tickers: $SPRY
Topics: investor_protection pharmaceuticals stock_price_drop